Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion (EMPHILINE)

August 31, 2015 updated by: University Hospital, Tours
The main objective is to compare the physiological reactivity (heart and respiratory rates, galvanic skin response, cerebral perfusion, and startle) in the three phases of emotion between depressive subjects, subjects remitted from depression and control subjects.

Study Overview

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tours, France, 37044
        • University Hospital of Tours

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female between 18 and 55
  • Informed consent form signed
  • Affiliated to a medical insurance
  • visual and hearing abilities suitable for exams
  • for the depressive group (group D): major depressive disorder according to the DSM-IV criteria as evaluated by the MINI test and MADRS score ≥22
  • for the depressive patients in remission's group (group R) : matched on age, at least 1 history of major depressive disorder in the last 10 years and solved for more than 6 months, and MADRS score < 9
  • for the control subjects (group T) : matched on age, no psychiatric history, MADRS score < 9

Exclusion Criteria:

  • psychotic disorder, bipolar disorder, addiction, suspected dementia (MMSE<25)
  • current betablockers or neuroleptics treatment
  • any current organic unstable pathology
  • history of serious cardiovascular disease (coronary syndrome, cardiac arrythmia, etc.)
  • smoking > 10 PY
  • history of serious neurologic disease (stroke, cerebral tumour, serious cranial trauma, headache, ...)
  • contra-indication to MRI
  • uncorrected vision or audition troubles
  • patient under juridic protection
  • pregnancy, lactating or female without reliable contraception

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: 3 groups of subjects

3 groups: depressive subjects, subjects remitted from depression and control subjects, with the same interventions.

psychometric tests, MRI, transcranial doppler and TPI, explicitative interview

NEO-PI, MADRS, MINI depression, MMSE, STAI-E, ERD, Anhedonia
ASL, rest f-MRI, FLAIR, white matter hyper intensities load
transcranial doppler TPI
Other Names:
  • Tissue Pulsatility Imaging

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
amplitude variations of heart and respiratory rate, cerebral pulsatility, galvanic skin response and startle as measure of physiological reactivity
Time Frame: one day
amplitude variations of heart and respiratory rate, cerebral pulsatility, galvanic skin response and startle.
one day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRI data as measure of cerebral perfusion, volume of leukoaraiosis and default network (fMRI at rest)
Time Frame: one day
cerebral perfusion measured by MRI (Arterial Spin Labelling) volume of leukoaraiosis default network (fMRI at rest)
one day
ultrasound data of doppler as measure of cerebral pulstility
Time Frame: one day
doppler index of middle cerebral artery At the same time, heart rate variability and cerebral pulsatility at rest will be collected
one day
score of psychometric tests as measure of emotional state
Time Frame: one day
MADRS score, ERD score, STAI-E score, anhedonia score, Neo-PI score, and the subjective assessment of emotional arousal (self Manikin assessment).
one day
spontaneous verbal production to emotional pictures and explicitative interviews
Time Frame: one day
spontaneous verbal production to emotional pictures and explicitative interviews
one day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

October 29, 2013

First Submitted That Met QC Criteria

December 31, 2013

First Posted (Estimate)

January 3, 2014

Study Record Updates

Last Update Posted (Estimate)

September 1, 2015

Last Update Submitted That Met QC Criteria

August 31, 2015

Last Verified

August 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Depressive Disorder

Clinical Trials on psychometric tests

3
Subscribe